...million) in a series A round led by Oriza Seed, with participation by Hygeia Capital, Ming Bioventures...

...ABM Therapeutics Inc.’s financing, which saw participation by new investors Sinopharm Capital, Panlin Capital and Ming Bioventures...

...of global BD, told BioCentury. New investors Tencent, GTJA Investment Group, Dyee Capital, Oriza Holdings, Ming Bioventures...